Abiopharma

New Form SCHEDULE 13D - BiomX Inc. <b>Filed:</b> 2026-01-26 <b>AccNo:</b> 0001213900-26-007701 <b>Size:</b> 33 KB

New Form DEF 14A - ENANTA PHARMACEUTICALS INC <b>Filed:</b> 2026-01-26 <b>AccNo:</b> 0001193125-26-022558 <b>Size:</b> 3 MB

New Form SCHEDULE 13D/A - Armata Pharmaceuticals, Inc. <b>Filed:</b> 2026-01-26 <b>AccNo:</b> 0001140361-26-002376 <b>Size:</b> 18 KB

New Form DEFA14A - KALA BIO, Inc. <b>Filed:</b> 2026-01-26 <b>AccNo:</b> 0001829126-26-000561 <b>Size:</b> 16 KB

New Form SCHEDULE 13G - Voyager Therapeutics, Inc. <b>Filed:</b> 2026-01-26 <b>AccNo:</b> 0001104659-26-006592 <b>Size:</b> 18 KB

New Form S-8 POS - Indivior Pharmaceuticals, Inc. <b>Filed:</b> 2026-01-26 <b>AccNo:</b> 0001193125-26-022554 <b>Size:</b> 87 KB

New Form 3 - MAINZ BIOMED N.V. <b>Filed:</b> 2026-01-26 <b>AccNo:</b> 0001213900-26-007696 <b>Size:</b> 6 KB

New Form 3 - MAINZ BIOMED N.V. <b>Filed:</b> 2026-01-26 <b>AccNo:</b> 0001213900-26-007695 <b>Size:</b> 7 KB

New Form S-8 POS - Indivior Pharmaceuticals, Inc. <b>Filed:</b> 2026-01-26 <b>AccNo:</b> 0001193125-26-022544 <b>Size:</b> 87 KB

New Form SCHEDULE 13G/A - Jasper Therapeutics, Inc. <b>Filed:</b> 2026-01-26 <b>AccNo:</b> 0001636587-26-000002 <b>Size:</b> 12 KB

New Form 25-NSE/A - Astria Therapeutics, Inc. <b>Filed:</b> 2026-01-26 <b>AccNo:</b> 0001354457-26-000086 <b>Size:</b> 3 KB

New Form SCHEDULE 13G - BIODESIX INC <b>Filed:</b> 2026-01-26 <b>AccNo:</b> 0000898432-26-000061 <b>Size:</b> 24 KB

Jin Medical International Ltd. To Host Management Fireside Chat

CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Integer Holdings Corporation (NYSE: ITGR) Investors to Inquire About a Securities Fraud Class Action by February 9, 2026

Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza